Pfizer to acquire cancer drug maker Medivation, and other MoneyWatch headlines
Pfizer buying prostate cancer specialist Medivation for $14B; ex-NBA star Kobe Bryant to launch venture capital fund; and heavy flooding threatens U.S. rice harvest. These headlines and more from CBS MoneyWatch.